Gentaur Vandortuzumab – Anti-STEAP1 Antibody

Gentaur Vandortuzumab – Anti-STEAP1 Antibody

Targets STEAP1, a transmembrane protein overexpressed in prostate and other cancers. Ideal for antibody–drug conjugate development.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 € Tax Excluded

1,234,567.00 € Tax Excluded

This combination does not exist.

Add to cart Buy now

More Information

This content will be shared across all product pages.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Customer Reviews